METASTATIC ADENOID CYSTIC CARCINOMA
Clinical trials for METASTATIC ADENOID CYSTIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC ADENOID CYSTIC CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC ADENOID CYSTIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets rare Cancer's genetic driver
Disease control Recruiting nowThis early-stage study is testing a new oral medication called REM-422 for people with advanced adenoid cystic carcinoma (ACC), a rare cancer. The main goals are to find a safe and effective dose and to see if the drug can shrink or control tumors. The study will enroll about 100…
Matched conditions: METASTATIC ADENOID CYSTIC CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Remix Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Targeted radiation blasts early cancer spread in new trial
Disease control Recruiting nowThis study is testing whether using a highly focused type of radiation (SBRT) early on can help control cancer that has spread to a few sites. It will compare this approach to standard care in about 32 patients with adenoid cystic carcinoma. The main goals are to see if it delays…
Matched conditions: METASTATIC ADENOID CYSTIC CARCINOMA
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC